7 medtech stories we missed: Feb. 17, 2017

February 17, 2017 By Danielle Kirsh Leave a Comment

Several companies released diabetes study results this week, while companies like BioTime closed on their public offerings and Pixium implanted its first bionic eye. Here are 7 medtech stories we missed this week, but were still worth mentioning.

1. Insulet touts glucose control study

Insulet Corp. announced the results from its first feasibility study of its Omnipod Horizon hybrid closed-loop system in a Feb. 17 news release. The positive results showed that the glucose control algorithm performed well and was safe to used day and night for adults who have type 1 diabetes. It also showed that it was effective at night with minimal hypoglycemia and fasting glucose. The Insulet study had 24 participants with type 1 diabetes and took place over a 36 hour period. The participants used a modified version of the Omnipod, a Dexcom continuous glucose sensor, and a model predictive control algorithm created by Insulet.

2. Pixium announces first Spanish implantation of Iris II ‘bionic eye’

The Institute of Ocular Microsurgery in Barcelona, Spain implanted the bionic vision system Iris II in the first Spanish patient, according to a Feb. 16 news release. The vision system has a bio-inspired camera and a 150-electrode epiretinal implant that can be removed if needed. Pixium Vision developed the bionic vision system to help patients who have lost their eyesight, and the Iris II is designed to help patients who lost their eyesight from retinitis pigmentosa. The surgery was performed by Dr. Borja Corcostegui, founder and medical director of the Institute of Ocular Microsurgery and a vitreoretinal surgeon.

3. Valeritas releases data for V-Go wearable insulin delivery device

Valeritas Holdings recently touted in a Feb. 16 news release that its V-Go Wearable Insulin Delivery device proved to have a greater reduction in A1c and insulin dose in patients who have type 2 diabetes. The study analyzed the electronic medical records from a multicenter diabetes system in the U.S. It evaluated the data of 107 patients to determine that patients had fewer insulin doses and needle sticks while using the V-Go, compared to using insulin pens.

4. Polyganics’ Stop Neuroma study shows reduction in pain

Polyganics announced in a Feb. 16 news release that its Stop Neuroma study has shown a sharp improvement in pain reduction in patients who participated in the program. The Stop Neuroma (surgical treatment of symptomatic neuroma) program was designed to determine how well the Polyganics Neurocap worked for reducing painful neuroma formation. The Neurocap is a nerve capping device that is the only approved dedicated device for managing symptomatic neuromas surgically. Patients saw an average pain reduction of 84% after a 3 month use, and patients who used it for 12 months felt they had improvement in daily functioning and quality of life.

5. BioTime closes public offering

BioTime has closed its underwritten public offering, according to a Feb. 15 news release. It sold 7,453,704 shares of its common stock at an offering of $2.70 per share. The company raked in approximately $20.1 million before the deduction of underwriting discounts, commissions and other expenses. BioTime will use the proceeds from the offering to fund clinical trials, research and development activities, general working capital and general corporate purposes.

6. Tandem Diabetes Care: Data shows its sensor-augmented pump has advantages over Medtronic

Tandem Diabetes Care recently did a study that compared data from its sensor-augmented pumps (SAPs) to Medtronic’s Minimed. According to a Feb. 15 news release, the Tandem SAP had significant clinical advantages like a reduction in hypoglycemia, increased time in range and an improved glycemic control. The data showed that about half of Medtronic SAP users were actively using a feature that suspended insulin delivery when blood glucose levels fell below a certain threshold. Both sets of data from Tandem and Medtronic used patients with type 1 and type 2 diabetes who used a SAP for at least 6 months and used a continuous glucose monitor for more than 15 days during the first 6 months.

7. FDA green-lights FlowAid Medical’s FA100 SCCD circulation aid

FlowAid Medical received FDA clearance this week for its FA100 SCCD (sequential continuous contraction device), according to a Feb. 15 news release. The FA100 SCCD is a handheld 4-channel electrical muscle stimulator that is small, lightweight and portable and provides low-frequency stimulation in sequential patterns. it requires no external pressure to the legs and allows the patient to move freely without interfering with daily activities. It is used on patients who have an increase of local blood circulation, immediate post-surgical stimulation of calf muscles to prevent venous thrombosis, and for the prevention or stopping of disuse atrophy and edema reduction. The FA100 SCCS also received CE Mark approval in July 2016 and Health Canada approval in August 2016.

Here’s what we missed last week.

Plastikos implements bio-contamination testing and compliance under ISO 14698
Plastikos (Erie, Pa.) recently announced that it has implemented a formal bio-contamination testing and compliance system that’s in full compliance with ISO 14698-1 and ISO 14698-2 — a move the company described as paramount amid the COVID-19 pandemic. Plastikos and Plastikos Medical presently mold medical devices and parts within multiple ISO-7 certified cleanrooms. The new… […]
How 3D printing is enabling ventilator splitting
Amid the shortage of ventilators due to the COVID-19 pandemic, researchers are finding success using 3D printing to enable “ventilator splitting.” The search continues to go on for more machines, but there have already been government actions taken to increase amounts, while researchers have taken it into their own hands to create homemade-style ventilators. However,… […]
How R&D departments are coping with coronavirus
Hardly anyone’s R&D workplace has been spared all the repercussions of the COVID-19 crisis. People are working remotely, staggering their hours in laboratories to avoid too many coworkers, and relying heavily on conference calls and video meetings. Our WTWH Media sister site R&D World spoke to a few industry people to see how they’re coping… […]
Europe waives tariffs, import taxes on COVID-19 medtech
The European Commission has decided to waive tariffs and value-added taxes (VAT) on certain medical devices and personal protective equipment (PPE) coming from outside the EU during the coronavirus pandemic. The measure includes testing kits, ventilators and other medical equipment and will remain in force for six months, the commission said today. “In this emergency,… […]
FDA eases mask regulations, seeks to boost decontamination of used masks
The FDA yesterday further relaxed regulations on medical and surgical masks and face shields to ease shortages during the coronavirus pandemic, and invited companies that decontaminate masks to submit proposals for emergency authorizations. In a new guidance, the agency also gave its blessing to healthcare providers to use improvised masks during the public health emergency when… […]
BARDA opens research portal to fight COVID-19
By James Keller, Emergo Group The Biomedical Advanced Research and Development Authority (BARDA), which is part of the US Health and Human Services Office of the Assistant Secretary for Preparedness and Response, is seeking information from stakeholders on available medical countermeasures in development. It is particularly interested in products and technologies that have progressed into… […]
Group seeks manufacturers’ input to reduce medical supply shortages
The National Center for Manufacturing Sciences (NCMS) today announced a new partnership with the U.S. Department of Defense (DOD) and the Federal Emergency Management Agency (FEMA) to reduce the critical shortage of medical equipment and supplies due to the coronavirus pandemic. The industry organization said it is seeking feedback from advanced manufacturing companies about capability,… […]
What is medical tubing used for?
Medical tubing is designed for a number of applications that allow clinicians to administer fluid and devices or allow for gas flow. Common applications of medical tubing include ventilators and IVs, but tubing also finds uses supporting access devices and as a delivery method for other devices. For example, tubing can be used to drive […]
Hack the Crisis: Clippard expects growth as it increases production for ventilator pneumatics
Mary Gannon, Fluid Power World Cincinnati-based Clippard said today it expects to hire more staff to meet the growing demand for its components and subassemblies for ventilators, diagnostic equipment and other critical care devices to help fight the coronavirus. The company manufactures valves, electronic pressure controls, custom assemblies, cylinders, air-preparation equipment and fittings for hose… […]
EPA inspector general wants more public input on ethylene oxide exposure
The U.S. Environmental Protection Agency’s inspector general this week recommended opening a channel of communication between government officials and people who live near 25 plants that use ethylene oxide (EtO), including eight used for sterilizing medical devices. But EPA administrator Andrew Wheeler objected, publicly indicating that his office was blindsided by the request. The forum… […]
Don’t curb your enthusiasm, but be realistic about MacGyver ventilators
In a coronavirus pandemic in which patients on the best commercial ventilators will die, are garage enthusiasts ready to stand behind their work? Scott Thielman, Product Creation Studio Almost a decade ago, Dr. Robert Clark, a pulmonologist then at Regional Hospital for Respiratory and Complex Care near Seattle, approached my company with a warning and an… […]